HOME › 教室紹介 › 研究 › 業績

業 績

主要な研究業績(2011~2014)

  • Mabuchi Y, Yahata, T, Kobayashi A, Tanizaki Y, Minami S, Ino K. A case of a young woman with vaginal carcinoma who underwent fertility-sparing treatment by chemotherapy and conservative surgery. J Obstet Gynaecol Res. 2014 Dec 16. doi:10.1111/jog.12638. [Epub ahead of print]
  • Kobayashi T, Minami S, Mitani A, Tanizaki Y, Booka M, Okutani T, Yamaguchi S, Ino K. Acute fatty liver of pregnancy associated with fetal mitochondrial trifunctional protein deficiency. J Obstet Gynaecol Res. 2014 Nov 25. doi:10.1111/jog.12609. [Epub ahead of print]
  • Tanizaki Y, Kobayashi A, Toujima S, Shiro M, Mizoguchi M, Mabuchi Y, Yagi S, Minami S, Takikawa O, Ino K. Indoleamine 2,3-dioxygenase promotes peritoneal metastasis of ovarian cancer via inducing immunosuppressive environment. Cancer Sci 105: 966-973, 2014.
  • Tanizaki Y, Kobayashi A, Shiro M, Ota N, Takano R, Mabuchi Y, Yagi S, Minami S, Terada M, Ino K. Diagnostic value of preoperative SUVmax on FDG-PET/CT for the detection of ovarian cancer. Int J Gynecol Cancer 24 :454-60, 2014
  • Mizoguchi M, Minami S, Yamamoto M, Tanizaki Y, Kobayashi A, Ino K. Ovarian steroid cell tumor, not otherwise specified, producing testosterone. J Obstet Gynecol Res 40: 2081-2085, 2014.
  • Kobayashi A, Minami S, Tanizaki Y, Shiro M, Yamamoto M, Yagi S, Okutani T, Kumagai T, Higuchi R, Ino K. Adverse perinatal and neonatal outcomes in patients with chronic abruption-oligohydramnios sequence. J Obstet Gynaecol Res 40:1618-1624, 2014
  • Kondo S, Demachi-Okamura A, Hirosawa T, Maki H, Fujita M, Uemura Y, Akatsuka Y, Yamamoto E, Shibata K, Ino K, Kikkawa F, Kuzushima K. An HLA-modified ovarian cancer cell line induced CTL responses specific to an epitope derived from claudin-1 presented by HLA-A*24:02 molecules. Hum Immunol 74:1103-1110, 2013
  • Yasuoka H, Tsujimoto M, Ueda M, Kodama R, Iwahashi Y, Inagaki M, Mabuchi Y, Ino K, Sanke T, Nakamura Y. Monoclonality of composite large-cell neuroendocrine carcinoma and invasive intestinal-type mucinous adenocarcinoma of the cervix: a case study. Int J Gynecol Pathol 32:416-420, 2013
  • Niimi K, Yamamoto E, Fujiwara S, Shinjo K, Kotani T, Umezu T, Kajiyama H, Shibata K, Ino K, Kikkawa F. High expression of N-acetylglucosaminyltransferase IVa promotes invasion of choriocarcinoma. Br J Cancer 107:1969-1977, 2012
  • Iwahashi M, Muragaki Y, Ino K. Human prolyl hydroxylase expression in uterine leiomyoma during the menstrual cycle. Reprod Biol Endocrinol 10:111, 2012
  • Ino K, Tanizaki Y, Kobayashi A, Toujima S, Mabuchi Y, Minami S. Role of the immune tolerance-inducing molecule indoleamine 2,3-dioxygenase in gynecologic cancers. J Cancer Sci Ther 4: S13:1-5, 2012
  • Kishi K, Mabuchi Y, Sonomura T, Shirai S, Noda Y, Sato M, Ino K. Eradicative brachytherapy with hyaluronate gel injection into pararectal space in treatment of bulky vaginal stump recurrence of uterine cancer. J Radiation Res 53: 601-607, 2012
  • Yasuoka H, Tsujimoto M, Inagaki M, Kodama R, Tsuji H, Iwahashi Y, Mabuchi Y, Ino K, Sanke T, Nakamura Y. Clinicopathological significance of podocalyxin and phosphorylated ezrin in uterine endometrioid adenocarcinoma. J Clin Pathol 65:399-402, 2012
  • Kishi K, Tamura S, Mabuchi Y, Sonomura T, Noda Y, Nakai M, Sato M, Ino K, Yamanaka N. Percutaneous interstitial brachytherapy for adrenal metastasis: technical report. J Radiat Res 53 : 807-814, 2012.
  • Kotani T, Sumigama S, Tsuda H, Mano Y, Yamamoto E, Iwase A, Shimoyama Y, Nagasaka T, Hayakawa H, Yamamoto T, Ino K, Kikkawa F. A case report of placental mesenchymal dysplasia with an increased VEGF-D expression. Placenta 33:888-891, 2012.
  • Maeda O, Shibata K, Hosono S, Fujiwara S, Kajiyama H, Ino K, Nawa A, Tamakoshi K, Kikkawa F. Spectrin aII and bII tetramers contribute to platinum anticancer drug resistance in ovarian serous adenocarcinoma. Int J Cancer 130: 113-121, 2012.
  • Kajiyama H, Shibata K, Suzuki S, Ino K, Kawai M, Nagasaka T, Nawa A, Kikkawa F. Survival impact of adjuvant paclitaxel and carboplatin for early-stage ovarian clear-cell carcinoma with complete surgical staging. Gynecol Obstet Invest 72 :252-6, 2011
  • Iwahashi M, Muragaki Y, Ikoma M, Mabuchi Y, Kobayashi A, Tanizaki Y, Ino K. Immunohistochemical analysis of collagen expression in uterine leiomyoma during the menstrual cycle. Exp Therap Med 2: 287-290, 2011.
  • Shibata K, Umezu T, Sakurai M, Kajiyama H, Yamamoto E, Ino K, Nawa A, Kikkawa F. Establishment of cisplatin-resistant ovarian yolk sac tumor cells and investigation of the mechanism of cisplatin resistance using this cell line. Gynecol Obstet Invest 71:104-111, 2011
  • Ino K. Indoleamine 2,3-dioxygenase and immune tolerance in ovarian cancer. Curr Opin Obstet Gynecol 23:13-18, 2011.
  • Ino K, Shibata K, Yamamoto E, Kajiyama H, Nawa A, Mabuchi Y, Yagi S, Minami S, Tanizaki Y, Kobayashi A, Kikkawa F. Role of the renin-angiotensin system in gynecologic cancers. Curr Cancer Drug Targets 11:405-411, 2011.


トップへ